← Search

Data · dataset · 2026

<p>Vaccine-induced immunity is activated after infection but is overcome by <i>F. tularensis</i> FSC200.</p>

Listed in ZivaHub

<p>(A) Mice immunized with a peptide vaccine (PepVac) or treated with the same adjuvant but without peptides (control) were subcutaneously infected with 53 CFU of <i>F. tularensis</i> FSC200, and the vaccine’s protective efficacy was evaluated.

Description

(B) Changes in body weight of mice during infection. The body weight of the mice on the day of infection (day 0) was used as the baseline, and the graph shows the percentage changes relative to that day.

Data from the four days prior to infection are also included. Values are presented as mean ± SD (one-sided). The data (days 1-5) were analyzed using a mixed-effects model with repeated measures, and multiple comparisons (PepVac versus control at individual time points) were corrected using Sidak’s post hoc test.

Read the rest (5 more)

An asterisk indicates a p-value < 0.05 for the interaction effect between time and treatment. (C) Survival curve for the vaccinated group (n = 8) and the control group of mice (n = 7). The dashed line indicates the median survival time for each group.

The data were analyzed using the Kaplan-Meier method with the log-rank test (ns for p ≥ 0.05).

Note

The unequal group sizes were due to the death of one mouse after administration of a booster dose as part of the immunization. The bacterial load in the spleen (D) and liver (E) of control and vaccinated mice (n = 5) was determined on day 4 postinfection. Data for individual mice and the corresponding mean values are shown.

A two-tailed t-test was used to assess statistical significance. Asterisks indicate p-values < 0.05. This experiment was performed once.</p>

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 1 source records, 13 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3402693713 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancermapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Cancer']
concepts[field].anzsrc:field:320211mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Infectious Diseases']
concepts[field].anzsrc:group:3101mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Cell Biology']
concepts[field].anzsrc:group:3107mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Microbiology']
concepts[field].anzsrc:group:3204mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Immunology']
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:life-sciencesmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:medicine-healthmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
licensesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/rights
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title